Kyowa Kirin Co., Ltd. (協和キリン株式会社, Kyōwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.[4][5]
^"Kyowa Hakko Kirin Company Overview". Kyowa Hakko Kirin. Retrieved March 14, 2014.
^"Kyowa Hakko Kirin Corporate Profile" (PDF). Kyowa Hakko Kirin. Retrieved March 14, 2014.
^"Kyowa Hakko Kirin Annual Report 2012". Kyowa Hakko Kirin. Retrieved March 14, 2014.
^"Components:Nikkei Stock Average". Nikkei Inc. Retrieved January 20, 2015.
^"Top 50 Pharma Companies by 2012 Revenue". Wildwood Ventures Ltd. Archived from the original on February 8, 2014. Retrieved March 14, 2014.
KyowaKirin Co., Ltd. (協和キリン株式会社, KyōwaKirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is...
Japanese beverages company KyowaKirin, a Japanese pharmaceutical company Brasil Kirin, a Brazilian brewery and beverage company Kirin processors, a series...
outstanding shares in Kyowa Hakko Bio Co. Ltd, from Kyowa Hakko Kirin to expand to wellness and bio-chemical products. On August 6, 2019, Kirin Holdings announced...
into a culture broth from which L-glutamate is isolated. Kyowa Hakko Kogyo (currently KyowaKirin) developed industrial fermentation to produce L-glutamate...
with KRAS-G12C-mutated non-small cell lung cancer. In June, Amgen and KyowaKirin announced joint plans to develop and commercialize a treatment for atopic...
prevention of organ transplant rejection. This drug was developed by KyowaKirin Pharmaceutical Development Inc. World Health Organization (2015). "International...
in October 2022, marked the firm's second location in Asia. Japan's KyowaKirin acquired Orchard Therapeutics for $477.6 million. Goodwin advised the...
September 12, 2008. Sancuso is manufactured by 3M Drug Delivery Systems for KyowaKirin, Inc. It was patented in 1985 and approved for medical use in 1991. It...
(11): 2055–2060. doi:10.1016/j.bmcl.2018.04.055. PMID 29724589. "Kyowa Hakko Kirin Launches Orkedia Tablets (Evocalcet) for the Treatment of Secondary...
bought SunTelephone with Bain Capital. In 2010 it bought Kyowa Hakko Chemical from Kyowa Hakko Kirin. In 2012 Japan Industrial partners bought the core operations...
relief. Such a declaration was granted for the first time in Fujifilm KyowaKirin Biologics Company Ltd v Abbvie Biotechnology Ltd [2017] EWHC 395 (Pat)...
medical use in the United States in 2019. and approval was granted to KyowaKirin, Inc. ADORA2A inhibition with Istradefylline may be a therapeutic approach...
collaboration between Kouji Matsushima of University of Tokyo and Kyowa Hakko Kirin. Kyowa humanized it, and expressed the humanized gene in a CHO cell line...
developed by Ultragenyx and is in a collaborative license agreement with Kyowa Hakko Kirin. "Crysvita". Therapeutic Goods Administration (TGA). 17 September...
share, is the largest of the four major beer brewers in Japan followed by Kirin Beer with 34% and Suntory with 16%. In response to a maturing domestic Japanese...
It is not hygroscopic and not optically active. It was discovered at KyowaKirin and developed by Aveo Pharmaceuticals.[non-primary source needed] The...
formalized its ties with UC San Diego, maintained its relationship with KyowaKirin, expanded its core facilities and technologic prowess, increased its...
King (subsidiary of Pfizer; 1994– ) Kissei (1946– ) Kite (2009– ) Kyowa Hakko Kirin (1949– ) Laboratoires Pierre Fabre (1951– ) Leo (1908– ) Locus (2015–...
forms of many of these diseases. Reata has a licensing agreement with Kyowa Hakko Kirin for development and commercialization of bardoxolone methyl for CKD...
Clinical Trial with Tivantinib in Hepatocellular Carcinoma by Partner Kyowa Hakko Kirin in Japan". The Wall Street Journal. 4 February 2014. Archived from...
“Unicorn Stores (HK) Ltd.”, rather acquired by its subsidiary company Urban Kirin. Therefore, Uny became an indirect wholly owned subsidiary of the company...
GTx sold its rights to toremifene to ProStrakan, a subsidiary of Kyowa Hakko Kirin, for around $19 million, and terminated its agreement with Orion....
and Nippon Beer, as well as competition with the Osaka (now Asahi) and Kirin breweries led to a 1906 merger of Sapporo, Nippon, and Osaka breweries into...
"Tetraester of pentaerythritol", published 2012-03-01, assigned to Kyowa Hakko Kirin de Meijere, Armin; Kostikov, Rafael R.; Savchenko, Andrei I.; Kozhushkov...
converted to an ordinary bank named Kyowa Bank (協和銀行). Kyowa merged with Saitama Bank (埼玉銀行) in 1991 to form Kyowa Saitama Bank (協和埼玉銀行), renamed Asahi...
Global Information
(¥ 398.4 billion JPY) (FY 2022)